Octave Intelligence Ltd Q3 FY2026 earnings call

• Financial Performance: ARR grew 7% organically to $1.171 billion. Total revenue exceeded guidance at $415 million. Adjusted operating margin of 28% beat expectations.
• AI Strategy & Cerebrae Acquisition: AI is integrated into the platform strategy via a 'context layer.' The acquisition of Cerebrae enhances this by digitizing legacy plant drawings into knowledge graphs. Embedded AI capabilities moved from prototype to product (e.g., InConcert assistant, predictive pipe routing). Agentic AI workflows are being tested with customers, showing strong traction in reducing rework.
• Product & Platform: Internal AI usage reduced R&D cycle time by >25%. Multi-tenant SaaS products are scheduled for 2027 delivery. Octave named a leader in EAM and digital worker technologies by ARC Advisory Group.
• Go-to-Market: Cross-sell contributed >10% of new ARR. Renewals team consolidated globally, improving on-time renewal rates and uplift. Channel partnerships with Microsoft Azure Marketplace expanded.
• Capital Allocation: Board authorized a $200 million share repurchase program to offset dilution and provide flexibility. Balance sheet remains strong with ~$300 million cash and net debt of $222 million ($350 million pro-forma for Cerebrae).

Total revenue was $415 million, up 6% organically. Recurring revenue (subscription licenses, SaaS, and maintenance) totaled $291 million, growing 5% organically. SaaS revenue grew 17-18% to $91 million, representing roughly one-third of total ARR. Monthly subscription license revenue grew 6%, while maintenance revenue was $125 million. Adjusted operating margin was 28%, up ~100 basis points year-over-year.

• ARR Growth: Maintained full-year organic constant currency growth range of 6-8%. Reported ARR target maintained at $1.185-$1.205 billion.
• Recurring Revenue: Raised full-year outlook to $1.145-$1.150 billion, representing 5.5-6% organic constant currency growth (up from previous 3-5% range).
• Total Revenue: Narrowed full-year outlook to $1.64-$1.66 billion (midpoint $1.65 billion), representing 0.5-2% organic constant currency growth.
• Q4 2026 Specifics: Expected total revenue of $440-$460 million (flat YoY growth midpoint). Recurring revenue expected at $292-$297 million (5-6% growth). Adjusted operating margin expected at 31-32%.
• Margins: Full-year adjusted operating margin expected at ~30%; free cash flow margin at ~20%.

• Perpetual License Decline: Continued shift away from perpetual licenses creates variability in total revenue timing and mix.
• Macro/Regional Softness: APAC mixed performance; China softer due to timing of perpetual deals and difficult comparatives. Middle East uncertainty persists despite EMEA double-digit growth.
• Public Safety Timing: Large public safety deals referenced in prior quarters did not close in Q3; impact deferred to Q4 or next year.
• R&D Accounting: Lower R&D capitalization as products transition to SaaS cycles drags on reported adjusted operating margin, though underlying cash profitability remains strong.

Q: Analyst asked if Cerebrae’s AI tech is standalone or broadly applicable, and how it positions Octave competitively. / A: CEO stated Cerebrae is a key building block for the upcoming Octave platform launch, acting as the context ingestion engine for plants. It connects to existing products like InConcert, providing a unique competitive moat through deep asset context that general LLMs lack. The acquisition supports long-term growth beyond immediate financial metrics.

Q: Analyst questioned the Q4 guidance implying a momentum fall-off compared to Q3, asking if this reflects macro issues or numerical effects. / A: CFO explained the step-down was always part of the annual shape based on prior year comparisons. There has been no change in the operating environment. The slight revision to constant currency growth rates accounts for FX headwinds and the natural decline in perpetual license revenue, which is baked into the plan.

Q: Analyst asked about the split between within-pillar and cross-workflow cross-selling, and hurdles to accelerating cross-workflow sales. / A: CEO noted the split is roughly 50-50 and progress is satisfactory. The primary driver for future acceleration is the upcoming platform launch in early 2027, which will natively connect solutions across workflows, thereby removing technical silos and making cross-up selling more repeatable and impactful.

Q: Analyst asked about the monetization strategy for AI agents accessing Octave’s context and when multi-tenant SaaS launches. / A: CEO confirmed consumption-based pricing is the intended model for agents accessing system records, though details are early-stage. Regarding multi-tenant SaaS, major products will be upgraded in H1 2027. He clarified this platform upgrade drives adoption rather than cannibalizing license sales, as access to the system of record remains necessary.

Q: Analyst asked about the valuation multiples paid for Cerebrae relative to buybacks, given the high price tag. / A: CEO acknowledged the multiple appeared high but emphasized Cerebrae is a small, very high-growth company with unique synergies, unlike mature targets where lower multiples would apply. CFO added that M&A prioritizes growth integration, and share buybacks serve as a disciplined tool for excess cash once strategic acquisitions are secured.